--10-01falseQ200018218060001821806us-gaap:EmployeeStockOptionMember2020-10-042021-04-030001821806lesl:ABLCreditFacilityMembersrt:MinimumMemberus-gaap:BaseRateMember2021-10-032022-04-020001821806lesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMembersrt:MinimumMember2021-03-012021-03-310001821806us-gaap:RetainedEarningsMember2022-01-022022-04-020001821806us-gaap:NoncompeteAgreementsMember2021-10-032022-04-0200018218062022-04-020001821806us-gaap:FairValueInputsLevel2Memberlesl:TermLoanDueInTwentyTwentyEightMember2021-10-0200018218062021-10-032022-04-020001821806us-gaap:WorkersCompensationInsuranceMemberus-gaap:StandbyLettersOfCreditMember2022-04-020001821806us-gaap:RetainedEarningsMember2022-04-020001821806us-gaap:WorkersCompensationInsuranceMembersrt:MaximumMember2022-04-020001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-10-042021-04-030001821806us-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:EurodollarMember2021-04-012021-04-300001821806us-gaap:AdditionalPaidInCapitalMember2021-10-032022-04-020001821806us-gaap:EmployeeStockOptionMember2022-01-032022-04-020001821806us-gaap:CommonStockMember2022-01-022022-04-020001821806us-gaap:RetainedEarningsMember2021-01-032021-04-030001821806us-gaap:RetainedEarningsMember2021-04-030001821806us-gaap:NoncompeteAgreementsMember2022-04-020001821806lesl:DenverColoradoMedfordOregonAndWashingtonDcMember2021-10-032022-04-020001821806us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:RevolvingCreditFacilityMember2021-04-012021-04-300001821806lesl:DenverColoradoMedfordOregonAndWashingtonDcMember2020-10-032021-10-020001821806us-gaap:CommonStockMember2021-04-030001821806us-gaap:CommonStockMember2020-10-030001821806us-gaap:NoncompeteAgreementsMember2020-10-032021-10-020001821806us-gaap:OtherIntangibleAssetsMember2021-04-030001821806lesl:TrademarksAndTradeNameMember2021-10-032022-04-020001821806us-gaap:CustomerRelationshipsMember2021-10-032022-04-020001821806us-gaap:FairValueInputsLevel2Memberlesl:TermLoanDueInTwentyTwentyEightMember2022-04-020001821806us-gaap:OtherIntangibleAssetsMember2020-10-032021-10-020001821806us-gaap:CommonStockMember2021-10-020001821806lesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2021-04-030001821806lesl:TrademarksAndTradeNameMember2020-10-042021-04-030001821806us-gaap:TrademarksAndTradeNamesMember2020-10-042021-04-0300018218062021-01-032021-04-0300018218062020-10-042021-10-020001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-032021-04-0300018218062021-01-020001821806us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMemberlesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2022-04-020001821806srt:MinimumMemberlesl:ExplorerInvestmentPteLtdMember2021-12-140001821806us-gaap:FairValueMeasurementsRecurringMember2021-10-020001821806us-gaap:AdditionalPaidInCapitalMember2022-01-010001821806us-gaap:CommonStockMember2021-01-020001821806us-gaap:CommonStockMember2021-01-032021-04-030001821806us-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:BaseRateMember2021-04-012021-04-3000018218062021-12-160001821806us-gaap:WorkersCompensationInsuranceMembersrt:MaximumMember2021-10-020001821806us-gaap:TrademarksAndTradeNamesMember2021-10-020001821806us-gaap:AdditionalPaidInCapitalMember2020-10-042021-04-030001821806us-gaap:RetainedEarningsMember2021-10-032022-04-020001821806lesl:ABLCreditFacilityMembersrt:MinimumMemberus-gaap:EurodollarMember2021-10-032022-04-020001821806us-gaap:EmployeeStockOptionMember2021-10-032022-04-020001821806us-gaap:AdditionalPaidInCapitalMember2022-04-020001821806us-gaap:RevolvingCreditFacilityMember2021-04-012021-04-300001821806us-gaap:CommonStockMember2021-12-162021-12-160001821806us-gaap:EmployeeStockOptionMemberlesl:TwoThousandAndTwentyOmnibusIncentivePlanMember2020-10-012020-10-310001821806us-gaap:CommonStockMember2021-10-032022-04-020001821806lesl:TrademarksAndTradeNameMember2021-04-030001821806us-gaap:RevolvingCreditFacilityMemberus-gaap:StandbyLettersOfCreditMember2022-04-020001821806us-gaap:OtherIntangibleAssetsMember2021-10-020001821806us-gaap:RevolvingCreditFacilityMember2022-04-020001821806us-gaap:OtherIntangibleAssetsMember2022-04-020001821806us-gaap:NoncompeteAgreementsMember2020-10-042021-04-030001821806us-gaap:OtherIntangibleAssetsMember2021-10-032022-04-020001821806us-gaap:RestrictedStockUnitsRSUMember2021-10-032022-04-020001821806us-gaap:OtherIntangibleAssetsMember2020-10-042021-04-0300018218062022-01-010001821806us-gaap:EmployeeStockOptionMember2021-10-020001821806us-gaap:RevolvingCreditFacilityMember2021-10-032022-04-020001821806lesl:TermLoanMember2021-03-310001821806lesl:TermLoanMember2021-03-012021-03-310001821806us-gaap:RestrictedStockUnitsRSUMember2022-01-032022-04-020001821806lesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMembersrt:MaximumMemberlesl:TermLoanMember2021-03-012021-03-310001821806us-gaap:RevolvingCreditFacilityMember2021-04-030001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-10-032022-04-020001821806srt:MinimumMemberlesl:TermLoanMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMember2021-03-012021-03-310001821806lesl:ABLCreditFacilityMembersrt:MaximumMemberus-gaap:BaseRateMember2021-10-032022-04-020001821806lesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2021-10-020001821806us-gaap:NoncompeteAgreementsMember2021-04-030001821806us-gaap:TrademarksAndTradeNamesMember2021-04-030001821806us-gaap:AdditionalPaidInCapitalMember2022-01-022022-04-020001821806us-gaap:EmployeeStockOptionMember2021-10-032022-04-020001821806lesl:TermLoanMemberlesl:ABRMemberlesl:ApplicableRateMember2021-03-012021-03-3100018218062020-10-032021-10-020001821806us-gaap:CustomerRelationshipsMember2021-10-020001821806lesl:SeniorUnsecuredNotesMember2020-10-042021-04-030001821806lesl:TermLoanMember2021-01-022022-04-0300018218062021-12-162021-12-160001821806us-gaap:AdditionalPaidInCapitalMember2021-01-020001821806us-gaap:RestrictedStockUnitsRSUMember2022-04-020001821806us-gaap:RevolvingCreditFacilityMember2021-10-020001821806us-gaap:RetainedEarningsMember2021-01-020001821806srt:MaximumMemberlesl:TermLoanMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMember2021-03-012021-03-3100018218062022-01-022022-04-020001821806us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMemberlesl:TermLoanMember2021-03-012021-03-310001821806lesl:TrademarksAndTradeNameMember2021-10-020001821806lesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2022-04-020001821806us-gaap:RetainedEarningsMember2020-10-042021-04-030001821806us-gaap:TrademarksAndTradeNamesMember2020-10-032021-10-020001821806lesl:SeniorUnsecuredNotesMember2020-11-030001821806us-gaap:TrademarksAndTradeNamesMember2022-04-020001821806us-gaap:CustomerRelationshipsMember2021-04-030001821806us-gaap:CustomerRelationshipsMember2020-10-032021-10-020001821806us-gaap:CustomerRelationshipsMember2022-04-020001821806us-gaap:RestrictedStockUnitsRSUMember2021-10-020001821806us-gaap:CommonStockMember2021-12-030001821806us-gaap:RestrictedStockUnitsRSUMember2021-01-032021-04-030001821806us-gaap:AdditionalPaidInCapitalMember2020-10-030001821806us-gaap:NoncompeteAgreementsMember2021-10-0200018218062021-10-020001821806us-gaap:CommonStockMember2022-04-020001821806lesl:BubblesInvestorAggregatorLPMembersrt:MinimumMember2021-12-140001821806us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-032022-04-020001821806lesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMemberlesl:ABRMemberlesl:ApplicableRateMember2021-03-012021-03-310001821806us-gaap:CustomerRelationshipsMember2020-10-042021-04-030001821806us-gaap:FairValueMeasurementsRecurringMember2022-04-0200018218062020-10-042021-04-030001821806us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:EurodollarMember2021-04-012021-04-300001821806us-gaap:LondonInterbankOfferedRateLIBORMemberlesl:TermLoanMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMemberlesl:ApplicableRateMember2021-03-012021-03-3100018218062022-05-020001821806us-gaap:AdditionalPaidInCapitalMember2021-01-032021-04-030001821806us-gaap:AdditionalPaidInCapitalMember2021-10-020001821806us-gaap:EmployeeStockOptionMember2022-04-0200018218062020-10-030001821806us-gaap:RetainedEarningsMember2022-01-010001821806us-gaap:RevolvingCreditFacilityMembersrt:MaximumMemberus-gaap:BaseRateMember2021-04-012021-04-300001821806us-gaap:RestrictedStockUnitsRSUMember2021-10-032022-04-020001821806lesl:TrademarksAndTradeNameMember2022-04-0200018218062021-04-030001821806us-gaap:CommonStockMember2021-12-032021-12-030001821806us-gaap:TrademarksAndTradeNamesMember2021-10-032022-04-020001821806us-gaap:AdditionalPaidInCapitalMember2021-04-030001821806us-gaap:EmployeeStockOptionMember2021-01-032021-04-030001821806us-gaap:CommonStockMember2020-10-042021-04-030001821806us-gaap:LondonInterbankOfferedRateLIBORMemberlesl:FirstLienLeverageRatioLessThanOrEqualToTwoPointSevenFiveToOneMemberlesl:TermLoanMemberlesl:ApplicableRateMember2021-03-012021-03-310001821806lesl:TermLoanMemberlesl:ABRMemberlesl:FirstLienLeverageRatioGreaterThanTwoPointSevenFiveToOneHundredMemberlesl:ApplicableRateMember2021-03-012021-03-310001821806us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberlesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2021-10-032022-04-020001821806us-gaap:RestrictedStockUnitsRSUMember2020-10-042021-04-030001821806us-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMemberlesl:TermLoanDueOnMarchNineTwoThousandTwentyEightMember2022-04-020001821806us-gaap:RetainedEarningsMember2020-10-030001821806us-gaap:CommonStockMemberlesl:TwoThousandAndTwentyOmnibusIncentivePlanMember2022-04-020001821806us-gaap:RevolvingCreditFacilityMember2021-04-3000018218062022-01-032022-04-020001821806lesl:BubblesInvestorAggregatorLPAndExplorerInvestmentPteLtdMemberus-gaap:CommonStockMember2021-12-142021-12-140001821806lesl:ABLCreditFacilityMembersrt:MaximumMemberus-gaap:EurodollarMember2021-10-032022-04-020001821806lesl:TrademarksAndTradeNameMember2020-10-032021-10-020001821806us-gaap:CommonStockMember2022-01-010001821806us-gaap:RetainedEarningsMember2021-10-020001821806us-gaap:LondonInterbankOfferedRateLIBORMemberlesl:TermLoanMemberlesl:ApplicableRateMember2021-03-012021-03-31iso4217:USDxbrli:shareslesl:Statexbrli:purelesl:Locationxbrli:shareslesl:Numberiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 02, 2022

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

Commission File Number 001-39667

 

LESLIE’S, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

20-8397425

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

2005 East Indian School Road

Phoenix, AZ

85016

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (602) 366-3999

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

LESL

 

The Nasdaq Global Select Market

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesNo

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). YesNo

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

 

Smaller reporting company

 

 

 

 

 

 

 

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesNo

As of May 2, 2022, the Registrant had 182,838,623 shares of common stock, $0.001 par value per share, outstanding.

 

 

 


Table of Contents

Table of Contents

 

 

 

Page

PART I

FINANCIAL INFORMATION

 

Item 1.

Financial Statements

2

 

Condensed Consolidated Balance Sheets

2

 

Condensed Consolidated Statements of Operations

3

 

Condensed Consolidated Statements of Stockholders’ Deficit

4

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

25

Item 4.

Controls and Procedures

26

 

 

 

PART II

OTHER INFORMATION

 

Item 1.

Legal Proceedings

27

Item 1A.

Risk Factors

27

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

27

Item 3.

Defaults Upon Senior Securities

27

Item 4.

Mine Safety Disclosures

27

Item 5.

Other Information

27

Item 6.

Exhibits

28

 

 

 

Signatures

 

29

 

i


Table of Contents

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Actual results or outcomes could differ materially from those indicated in these forward-looking statements for a variety of reasons, including, among others:

our ability to execute on our growth strategies;
our ability to maintain favorable relationships with suppliers and manufacturers;
competition from mass merchants and specialty retailers;
impacts on our business from the sensitivity of our business to weather conditions, changes in the economy, and the housing market;
our ability to implement technology initiatives that deliver the anticipated benefits, without disrupting our operations;
our ability to attract and retain senior management and other qualified personnel;
regulatory changes and development affecting our current and future products;
our ability to obtain additional capital to finance operations;
commodity price inflation and deflation;
impacts on our business from the COVID-19 pandemic;
impacts on our business from cyber incidents and other security threats or disruptions; and
other risks and uncertainties, including those listed in the section titled “Risk Factors” in our filings with the United States Securities and Exchange Commission.

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended October 2, 2021, and elsewhere in this Quarterly Report on Form 10-Q, and in our other filings with the Securities and Exchange Commission. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results or outcomes could differ materially from those described in the forward-looking statements.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q and while we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Quarterly Report on Form 10-Q are based on events or circumstances as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.

1


Table of Contents

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

LESLIE’S, INC.

CONDENSED Consolidated Balance Sheets

(Amounts in Thousands, Except Share and Per Share Amounts)

 

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

 

 

(Unaudited)

 

 

(Audited)

 

 

(Unaudited)

 

Assets

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

51,971

 

 

$

343,498

 

 

$

88,732

 

Accounts and other receivables, net

 

 

33,619

 

 

 

38,860

 

 

 

41,733

 

Inventories

 

 

345,046

 

 

 

198,789

 

 

 

277,860

 

Prepaid expenses and other current assets

 

 

41,240

 

 

 

20,564

 

 

 

40,001

 

Total current assets

 

 

471,876

 

 

 

601,711

 

 

 

448,326

 

Property and equipment, net

 

 

70,547

 

 

 

70,335

 

 

 

63,632

 

Operating lease right-of-use assets

 

 

208,531

 

 

 

212,284

 

 

 

181,581

 

Goodwill and other intangibles, net

 

 

146,865

 

 

 

129,020

 

 

 

127,851

 

Deferred tax assets

 

 

2,429

 

 

 

3,734

 

 

 

15,293

 

Other assets

 

 

29,947

 

 

 

25,148

 

 

 

20,632

 

Total assets

 

$

930,195

 

 

$

1,042,232

 

 

$

857,315

 

Liabilities and stockholders’ deficit

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

268,475

 

 

$

233,597

 

 

$

262,266

 

Operating lease liabilities

 

 

61,612

 

 

 

61,071

 

 

 

55,395

 

Income taxes payable

 

 

 

 

 

6,945

 

 

 

 

Current portion of long-term debt

 

 

8,100

 

 

 

8,100

 

 

 

8,100

 

Total current liabilities

 

 

338,187

 

 

 

309,713

 

 

 

325,761

 

Operating lease liabilities, noncurrent

 

 

149,818

 

 

 

160,037

 

 

 

130,496

 

Revolving credit facility

 

 

45,000

 

 

 

 

 

 

 

Long-term debt, net

 

 

782,921

 

 

 

786,125

 

 

 

789,339

 

Other long-term liabilities

 

 

 

 

 

3,915

 

 

 

2,729

 

Total liabilities

 

 

1,315,926

 

 

 

1,259,790

 

 

 

1,248,325

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Stockholders’ deficit

 

 

 

 

 

 

 

 

 

Common stock, $0.001 par value, 1,000,000,000 shares authorized and 182,784,211, 189,821,011, and 186,884,621 issued and outstanding as of April 2, 2022, October 2, 2021, and April 3, 2021, respectively.

 

 

183

 

 

 

190

 

 

 

187

 

Additional paid in capital

 

 

83,074

 

 

 

204,711

 

 

 

194,605

 

Retained deficit

 

 

(468,988

)

 

 

(422,459

)

 

 

(585,802

)

Total stockholders’ deficit

 

 

(385,731

)

 

 

(217,558

)

 

 

(391,010

)

Total liabilities and stockholders’ deficit

 

$

930,195

 

 

$

1,042,232

 

 

$

857,315

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

2


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Operations

(Amounts in Thousands, Except Per Share Amounts)

(Unaudited)

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Sales

 

$

228,072

 

 

$

192,441

 

 

$

412,896

 

 

$

337,447

 

Cost of merchandise and services sold

 

 

142,443

 

 

 

120,758

 

 

 

259,951

 

 

 

214,049

 

Gross profit

 

 

85,629

 

 

 

71,683

 

 

 

152,945

 

 

 

123,398

 

Selling, general and administrative expenses

 

 

89,618

 

 

 

70,374

 

 

 

169,403

 

 

 

147,863

 

Operating (loss) income

 

 

(3,989

)

 

 

1,309

 

 

 

(16,458

)

 

 

(24,465

)

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

6,949

 

 

 

8,126

 

 

 

13,812

 

 

 

19,642

 

Loss on debt extinguishment

 

 

 

 

 

1,888

 

 

 

 

 

 

9,169

 

Other expenses, net

 

 

161

 

 

 

1,057

 

 

 

550

 

 

 

1,057

 

Total other expense

 

 

7,110

 

 

 

11,071

 

 

 

14,362

 

 

 

29,868

 

Loss before taxes

 

 

(11,099

)

 

 

(9,762

)

 

 

(30,820

)

 

 

(54,333

)

Income tax benefit

 

 

(3,659

)

 

 

(3,310

)

 

 

(8,929

)

 

 

(17,624

)

Net loss

 

$

(7,440

)

 

$

(6,452

)

 

$

(21,891

)

 

$

(36,709

)

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

Diluted

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

Diluted

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

3


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Stockholders’ Deficit

(Amounts in Thousands)

(Unaudited)

 

 

 

Common Stock

 

 

Additional
Paid in
Capital

 

 

Retained

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

(Deficit)

 

 

Deficit

 

 

Deficit

 

Balance, January 2, 2021

 

 

186,619

 

 

$

187

 

 

$

192,753

 

 

$

(579,350

)

 

$

(386,410

)

Issuance of common stock upon initial public offering, net of offering costs

 

 

 

 

 

 

 

 

(99

)

 

 

 

 

 

(99

)

Issuance of common stock under the Plan

 

 

266

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

 

 

 

 

 

 

 

 

1,951

 

 

 

 

 

 

1,951

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(6,452

)

 

 

(6,452

)

Balance, April 3, 2021

 

 

186,885

 

 

$

187

 

 

$

194,605

 

 

$

(585,802

)

 

$

(391,010

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, January 1, 2022

 

 

182,497

 

 

$

182

 

 

$

80,062

 

 

$

(461,548

)

 

$

(381,304

)

Issuance of common stock under the Plan

 

 

287

 

 

 

1

 

 

 

228

 

 

 

 

 

 

229

 

Equity-based compensation

 

 

 

 

 

 

 

 

2,784

 

 

 

 

 

 

2,784

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(7,440

)

 

 

(7,440

)

Balance, April 2, 2022

 

 

182,784

 

 

$

183

 

 

$

83,074

 

 

$

(468,988

)

 

$

(385,731

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Additional
Paid in
Capital

 

 

Retained

 

 

Total
Stockholders’

 

 

 

Shares

 

 

Amount

 

 

(Deficit)

 

 

Deficit

 

 

Deficit

 

Balance, October 3, 2020

 

 

156,500

 

 

$

157

 

 

$

(278,063

)

 

$

(549,093

)

 

$

(826,999

)

Issuance of common stock upon initial public offering, net of offering costs

 

 

30,000

 

 

 

30

 

 

 

458,557

 

 

 

 

 

 

458,587

 

Issuance of common stock under the Plan

 

 

385

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity-based compensation

 

 

 

 

 

 

 

 

14,111

 

 

 

 

 

 

14,111

 

Net loss

 

 

 

 

 

 

 

 

 

 

 

(36,709

)

 

 

(36,709

)

Balance, April 3, 2021

 

 

186,885

 

 

$

187

 

 

$

194,605

 

 

$

(585,802

)

 

$

(391,010

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, October 2, 2021

 

 

189,821

 

 

$

190

 

 

$

204,711

 

 

$

(422,459

)

 

$

(217,558

)

Issuance of common stock under the Plan

 

 

463

 

 

 

1

 

 

 

328

 

 

 

 

 

 

329

 

Equity-based compensation

 

 

 

 

 

 

 

 

5,535

 

 

 

 

 

 

5,535

 

Repurchase and retirement of common stock

 

 

(7,500

)

 

 

(8

)

 

 

(127,500

)

 

 

(24,638

)

 

 

(152,146

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

(21,891

)

 

 

(21,891

)

Balance, April 2, 2022

 

 

182,784

 

 

$

183

 

 

$

83,074

 

 

$

(468,988

)

 

$

(385,731

)

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

4


Table of Contents

LESLIE’S, INC.

CONDENSED Consolidated Statements of Cash Flows

(Amounts in Thousands)

(Unaudited)

 

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Operating Activities

 

 

 

 

 

 

Net loss

 

$

(21,891

)

 

$

(36,709

)

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

15,817

 

 

 

12,858

 

Equity-based compensation

 

 

5,535

 

 

 

14,111

 

Amortization of deferred financing costs and debt discounts

 

 

986

 

 

 

1,134

 

Provision for doubtful accounts

 

 

418

 

 

 

64

 

Deferred income taxes

 

 

1,305

 

 

 

(8,711

)

Loss (gain) on disposition of assets

 

 

118

 

 

 

(1,753

)

Loss on debt extinguishment

 

 

 

 

 

9,169

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts and other receivables

 

 

4,823

 

 

 

(10,316

)

Inventories

 

 

(132,358

)

 

 

(127,814

)

Prepaid expenses and other current assets

 

 

(20,306

)

 

 

(17,095

)

Other assets

 

 

(4,922

)

 

 

(6,150

)

Accounts payable and accrued expenses

 

 

26,588

 

 

 

64,007

 

Income taxes payable

 

 

(6,945

)

 

 

(1,857

)

Operating lease assets and liabilities, net

 

 

(5,925

)

 

 

(2,728

)

Net cash used in operating activities

 

 

(136,757

)

 

 

(111,790

)

Investing Activities

 

 

 

 

 

 

Purchases of property and equipment

 

 

(14,322

)

 

 

(9,490

)

Business acquisitions, net of cash acquired

 

 

(29,988

)

 

 

(6,040

)

Proceeds from disposition of fixed assets

 

 

407

 

 

 

2,404

 

Net cash used in investing activities

 

 

(43,903

)

 

 

(13,126

)

Financing Activities

 

 

 

 

 

 

Borrowings on revolving credit facility

 

 

45,000

 

 

 

 

Repayment of long-term debt

 

 

(4,050

)

 

 

(392,085

)

Issuance of long-term debt

 

 

 

 

 

907

 

Payment of deferred financing costs

 

 

 

 

 

(9,562

)

Proceeds from options exercised

 

 

329

 

 

 

 

Repurchase and retirement of common stock

 

 

(152,146

)

 

 

 

Proceeds from issuance of common stock upon initial public offering, net

 

 

 

 

 

458,587

 

Net cash (used in) provided by financing activities

 

 

(110,867

)

 

 

57,847

 

Net decrease in cash and cash equivalents

 

 

(291,527

)

 

 

(67,069

)

Cash and cash equivalents, beginning of period

 

 

343,498

 

 

 

155,801

 

Cash and cash equivalents, end of period

 

$

51,971

 

 

$

88,732

 

Supplemental Information:

 

 

 

 

 

 

Interest

 

$

13,325

 

 

$

27,081

 

Income taxes, net of refunds received

 

 

7,358

 

 

 

3,998

 

 

See accompanying notes which are an integral part of these condensed consolidated financial statements.

5


Table of Contents

LESLIE’S, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1—Business and Operations

Leslie’s, Inc. (“Leslie’s,” “we,” “our,” “us,” “its,” or the “Company”) is the leading direct-to-consumer pool and spa care brand. We market and sell pool and spa supplies and related products and services, which primarily consist of maintenance items such as chemicals, equipment and parts, and cleaning accessories, as well as safety, recreational, and fitness-related products. We currently market our products through 965 company-operated locations in 38 states and e-commerce websites.

Note 2—Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

We prepared the accompanying interim condensed consolidated financial statements following United States generally accepted accounting principles (“GAAP”). The financial statements include all normal and recurring adjustments that are necessary for a fair presentation of our financial position and operating results. The interim condensed consolidated financial statements include the accounts of Leslie’s, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. These interim condensed consolidated financial statements and the related notes included in our Annual Report on Form 10-K for the year ended October 2, 2021.

Fiscal Periods

We operate on a fiscal calendar that results in a fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to September 30th. In a 52-week fiscal year, each quarter contains 13 weeks of operations; in a 53-week fiscal year, each of the first, second and third quarters includes 13 weeks of operations and the fourth quarter includes 14 weeks of operations. References to the three months ended April 2, 2022 and the three months ended April 3, 2021 refer to the 13 weeks ended April 2, 2022 and April 3, 2021, respectively. References to the six months ended April 2, 2022 and the six months ended April 3, 2021 refer to the 26 weeks ended April 2, 2022 and April 3, 2021, respectively.

Use of Estimates

To prepare financial statements that conform to GAAP, we make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Our most significant estimates relate to sales returns, inventory obsolescence reserves, lease assumptions, vendor rebate programs, income taxes, self-insurance, valuation of intangible assets and goodwill, and intangible asset impairment evaluations. We continually review our estimates and make adjustments as necessary, but actual results could be significantly different from what we expected when we made these estimates.

Prior Period Reclassifications

Reclassifications of certain immaterial prior period amounts have been made to conform to current period presentation.

Fair Value Measurements

We use fair value measurements to record fair value of certain assets and to estimate fair value of financial instruments not recorded at fair value but required to be disclosed at fair value.

As of April 2, 2022 and October 2, 2021, we held no assets that are required to be measured at fair value on a recurring basis.

The fair value of our amended and restated term loan credit agreement (“Term Loan”) due in 2028 (see Note 9—Long-Term Debt, Net) was determined to be $790.9 million and $802.9 million as of April 2, 2022 and October 2, 2021, respectively. These fair value estimates, determined to be Level 2, are subjective in nature and involve uncertainties and matters of judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect these estimates.

The carrying amounts of cash, cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value due to the short-term maturity of these instruments.

There were no transfers between levels in the fair value hierarchy during the three and six months ended April 2, 2022 and April 3, 2021, respectively.

6


Table of Contents

Seasonality

Our business is highly seasonal. In general, sales and earnings are highest during our third and fourth fiscal quarters, being April through September, and represent the peak months of swimming pool use. Sales are substantially lower during our first and second fiscal quarters.

Recent Accounting Pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (“Topic 740”): Simplifying the Accounting for Income Taxes. ASU 2019-12 removes certain exceptions related to intraperiod tax allocations, foreign subsidiaries and interim reporting that are present within existing GAAP rules. The ASU also provides updated guidance regarding the tax treatment of certain franchise taxes, goodwill and nontaxable entities, among other items. In addition, ASU 2019-12 clarifies that the effect of a change in tax laws or rates should be reflected in the annual effective tax rate computation during the interim period that includes the enactment date. We adopted ASU 2019-12 as of October 3, 2021, (as of the beginning of the current annual period) and its adoption did not have a material impact on our consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which includes certain amendments to improve, simplify, and provide consistency for recognition and measurement of acquired contract assets and contract liabilities from revenue contracts in a business combination. The amendments require that an acquirer recognize and measure such contract assets and contract liabilities under Topic 606, Revenue from Contracts with Customers, as if it had originated the contracts. The amendments also allow for election of certain practical expedients, which are applied on an acquisition-by-acquisition basis. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including for any interim period, and if elected, the amendments are applied retrospectively for any acquisitions that occurred in the fiscal year of interim adoption. We adopted ASU 2021-08 during the second quarter of fiscal 2022 and its adoption did not have a material impact on our consolidated financial statements.

Note 3—Business Combinations

The following acquisitions did not have a material impact on our financial position or results of operations. Our condensed consolidated financial statements include the results of operations of these acquisitions from the date of acquisition. The total purchase consideration was allocated to the tangible and intangible assets acquired and the liabilities assumed at their estimated fair values as of each acquisition date, with the excess recorded to goodwill. The goodwill resulting from these acquisitions is expected to be deductible for income tax purposes. During the measurement periods, which will not exceed one year from each closing, we will continue to obtain information to assist us in finalizing the acquisition date fair values. Any qualifying changes to our preliminary estimates will be recorded as adjustments to the respective assets and liabilities, with any residual amounts allocated to goodwill.

Fiscal 2022 Acquisitions

During the six months ended April 2, 2022, we acquired two businesses for an aggregate purchase price of $30.0 million. These acquisitions expanded our pool and spa footprint and added 14 new retail locations. We are in the process of obtaining third-party valuations of certain intangible assets and inventories; thus, the provisional measurement of inventories, intangible assets and goodwill are subject to change. The following table sets forth the preliminary allocation of these acquisitions in the aggregate (in thousands):

 

Total purchase consideration, net of cash acquired

 

$

29,988

 

Less fair value of assets acquired and liabilities assumed:

 

 

 

Inventory

 

 

13,899

 

Intangibles

 

 

2,000

 

Other assets and liabilities, net

 

 

(1,644

)

Total assets acquired, net of liabilities assumed

 

 

14,255

 

Goodwill

 

$

15,733

 

 

7


Table of Contents

Fiscal 2021 Acquisitions

In fiscal 2021, we completed three acquisitions of retailers of supplies and services for hot tubs and swim spas with eight locations. During the six months ended April 2, 2022, we recorded measurement period adjustments resulting in an increase in goodwill of $1.5 million related to these acquisitions. The purchase accounting for two of the three acquisitions is complete.

Note 4 —Goodwill and Other Intangibles, Net

Goodwill

The following table details the changes in goodwill (in thousands):

 

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Balance at beginning of the period

 

$

101,114

 

 

$

93,295

 

 

$

93,295

 

Acquisitions

 

 

15,733

 

 

 

7,819

 

 

 

4,397

 

Measurement period adjustments

 

 

1,475

 

 

 

 

 

 

 

Balance at the end of the period

 

$

118,322

 

 

$

101,114

 

 

$

97,692

 

 

Other Intangible Assets

Other intangible assets consisted of the following as of April 2, 2022 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

9.2

 

 

$

7,940

 

 

$

(5,350

)

 

$

2,590

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

17,750

 

 

 

 

 

 

17,750

 

Non-compete agreements

 

 

7.0

 

 

 

8,683

 

 

 

(7,276

)

 

 

1,407

 

Consumer relationships

 

 

6.1

 

 

 

19,000

 

 

 

(12,513

)

 

 

6,487

 

Other intangibles

 

 

6.7

 

 

 

6,620

 

 

 

(6,311

)

 

 

309

 

Total

 

 

 

 

$

59,993

 

 

$

(31,450

)

 

$

28,543

 

 

Other intangible assets consisted of the following as of October 2, 2021 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

6.6

 

 

$

5,940

 

 

$

(5,274

)

 

$

666

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

17,750

 

 

 

 

 

 

17,750

 

Non-compete agreements

 

 

7.5

 

 

 

8,633

 

 

 

(7,123

)

 

 

1,510

 

Consumer relationships

 

 

6.4

 

 

 

19,000

 

 

 

(11,688

)

 

 

7,312

 

Other intangibles

 

 

7.0

 

 

 

6,620

 

 

 

(5,952

)

 

 

668

 

Total

 

 

 

 

$

57,943

 

 

$

(30,037

)

 

$

27,906

 

 

8


Table of Contents

Other intangible assets consisted of the following as of April 3, 2021 (in thousands, except weighted average remaining useful life):

 

 

Weighted
Average
Remaining
Useful Life
(in Years)

 

 

Gross
Carrying
Value

 

 

Accumulated
Amortization

 

 

Net
Carrying
Amount

 

Trade name and trademarks (finite life)

 

 

3.1

 

 

$

5,540

 

 

$

(5,195

)

 

$

345

 

Trade name and trademarks (indefinite life)

 

Indefinite

 

 

 

18,550

 

 

 

 

 

 

18,550

 

Non-compete agreements

 

 

8.9

 

 

 

9,833

 

 

 

(7,014

)

 

 

2,819

 

Consumer relationships

 

 

6.5

 

 

 

18,500

 

 

 

(10,853

)

 

 

7,647

 

Other intangibles

 

 

7.3

 

 

 

5,303

 

 

 

(4,505

)

 

 

798

 

Total

 

 

 

 

$

57,726

 

 

$

(27,567

)

 

$

30,159

 

 

Amortization expense was $0.1 million and $0.5 million for the three months ended April 2, 2022, and April 3, 2021, respectively. Amortization expense was $1.4 million and $1.0 million for the six months ended April 2, 2022, and April 3, 2021, respectively. No impairment of goodwill or other intangible assets was recorded during the three and six months ended April 2, 2022, and April 3, 2021, respectively.

The following table summarizes the estimated future amortization expense related to finite-lived intangible assets on our condensed consolidated balance sheet as of April 2, 2022 (in thousands):

 

 

Amount

 

Remainder of fiscal 2022

 

$

1,174

 

2023

 

 

2,123

 

2024

 

 

1,485

 

2025

 

 

1,388

 

2026

 

 

1,142

 

Thereafter

 

 

3,481

 

Total

 

$

10,793

 

 

Note 5—Accounts and Other Receivables, Net

Accounts and other receivables, net consisted of the following (in thousands):

 

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Vendor and other rebates receivable

 

$

20,519

 

 

$

23,222

 

 

$

29,288

 

Customer receivables

 

 

12,193

 

 

 

13,473

 

 

 

10,464

 

Other receivables

 

 

1,932

 

 

 

4,621

 

 

 

2,545

 

Allowance for doubtful accounts

 

 

(1,025

)

 

 

(2,456

)

 

 

(564

)

Total

 

$

33,619

 

 

$

38,860

 

 

$

41,733

 

 

Note 6—Inventories

Inventories consisted of the following (in thousands):

 

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Raw materials

 

$

9,595

 

 

$

4,244

 

 

$

4,274

 

Finished goods

 

 

335,451

 

 

 

194,545

 

 

 

273,586

 

Total

 

$

345,046

 

 

$

198,789

 

 

$

277,860

 

 

9


Table of Contents

Note 7—Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Prepaid expenses

 

$

21,209

 

 

$

12,814

 

 

$

23,809

 

Income taxes receivable

 

 

10,555

 

 

 

 

 

 

11,054

 

Other current assets

 

 

9,476

 

 

 

7,750

 

 

 

5,138

 

Total

 

$

41,240

 

 

$

20,564

 

 

$

40,001

 

 

Note 8—Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following (in thousands):

 

 

 

April 2,2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Accounts payable

 

$

160,909

 

 

$

100,960

 

 

$

181,524

 

Accrued payroll and employee benefits

 

 

20,050

 

 

 

40,071

 

 

 

20,492

 

Customer deposits

 

 

16,874

 

 

 

19,861

 

 

 

16,288

 

Interest

 

 

4,293

 

 

 

4,898

 

 

 

524

 

Inventory related accruals

 

 

15,072

 

 

 

12,444

 

 

 

10,544

 

Loyalty and deferred revenue

 

 

8,727

 

 

 

6,685

 

 

 

2,835

 

Sales taxes

 

 

11,807

 

 

 

13,975

 

 

 

11,741

 

Self-insurance reserves

 

 

11,182

 

 

 

7,679

 

 

 

5,039

 

Other accrued liabilities

 

 

19,561

 

 

 

27,024

 

 

 

13,279

 

Total

 

$

268,475

 

 

$

233,597

 

 

$

262,266

 

As of April 2, 2022 and October 2, 2021 there were capital expenditures included in other accrued liabilities of $2.0 million and $1.5 million, respectively. As of April 3, 2021 there were no capital expenditures included in other accrued liabilities.

Note 9—Long-Term Debt, Net

Our long-term debt, net consisted of the following (in thousands, except interest rates):

 

 

 

Effective
Interest Rate
(1)

 

 

April 2, 2022

 

 

October 2, 2021

 

 

April 3, 2021

 

Term Loan—due on March 9, 2028

 

 

3.02

%

(2)

$

801,900

 

 

$

805,950

 

 

$

810,000

 

Revolving Credit Facility

 

 

1.25

%

(3)

 

45,000

 

 

 

 

 

 

 

Total long-term debt

 

 

 

 

 

846,900

 

 

 

805,950

 

 

 

810,000

 

Less: current portion of long-term debt

 

 

 

 

 

(8,100

)

 

 

(8,100

)

 

 

(8,100

)

Less: noncurrent Revolving Credit Facility

 

 

 

 

 

(45,000

)

 

 

 

 

 

 

Less: unamortized discount

 

 

 

 

 

(3,046

)

 

 

(3,285

)

 

 

(3,519

)

Less: deferred financing charges

 

 

 

 

 

(7,833

)

 

 

(8,440

)

 

 

(9,042

)

Total long-term debt, net

 

 

 

 

$

782,921

 

 

$

786,125

 

 

$

789,339

 

 

(1)
Effective interest rates as of April 2, 2022.
(2)
Carries interest at a specified margin over LIBOR between 2.50% and 2.75% with a minimum LIBOR of 0.50%.
(3)
Carries interest at a specific margin between 0.25% and 0.75% with respect to Base Rate loans and between 1.25% and 1.75% with respect to Eurodollar Rate loans.  

10


Table of Contents

Term Loan

In March 2021, we entered into an amendment to our Term Loan. The amended Term Loan provides for an $810.0 million secured term loan facility with a maturity date of March 9, 2028. Borrowings under the Term Loan have an initial applicable rate, at our option of, (i) 2.75% for loans that are LIBOR loans and (ii) 1.75% of loans that are ABR loans. The applicable rate of the Term Loan is based on our first lien leverage ratio as follows: (a) if the first lien leverage ratio is greater than 2.75 to 1.00, the applicable rate will be 2.75% for LIBOR loans and 1.75% for ABR loans and (b) the first lien leverage ratio is less than or equal to 2.75 to 1.00, the applicable rate will be 2.50% for LIBOR loans and 1.50% for ABR loans. For LIBOR loans, the loans will bear interest at the adjusted LIBOR rate plus the applicable rate, where the adjusted LIBOR rate will not be less than 0.50%. As a result of the amendment during the three months ended April 3, 2021, we recognized a $1.9 million loss on debt extinguishment on our condensed consolidated statements of operations.

Revolving Credit Facility

In April 2021, we entered into Amendment No. 5 to our $200.0 million credit facility (the “Revolving Credit Facility”) maturing on August 13, 2025 (the “Amendment”). The Amendment has (i) an applicable margin on the Base Rate loans with a range of 0.25% to 0.75%, (ii) an applicable margin on the Eurodollar Rate loans with a range of 1.25% to 1.75%, (iii) a LIBOR floor of 0%, and (iv) a commitment fee rate of 0.25%.

We are also obligated to pay a commission on all outstanding letters of credit as well as customary administrative, issuance, fronting, amendment, payment, and negotiation fees. As of April 2, 2022, we had $45.0 million outstanding on the Revolving Credit Facility. As of October 2, 2021 and April 3, 2021, no amounts were outstanding on the Revolving Credit Facility, respectively. The amount available was reduced by $10.0 million of existing standby letters of credit as of April 2, 2022. Subsequent to April 2, 2022, we repaid the outstanding balance on the Revolving Credit Facility of $45.0 million.

Senior Unsecured Notes

The senior unsecured notes principal of $390.0 million was paid in full on November 3, 2020, resulting in a loss on debt extinguishment of $7.3 million on our condensed consolidated statements of operations for the six months ended April 3, 2021, respectively.

Representations and Covenants

Substantially all of our assets are pledged as collateral to secure our indebtedness. The Term Loan and the Revolving Credit Facility do not require us to comply with any financial covenants. The Term Loan and Revolving Credit Facility contain customary representations and warranties, covenants, and conditions to borrowing. No event of default had occurred as of April 2, 2022, October 2, 2021, or April 3, 2021.

Future Debt Maturities

The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of April 2, 2022 (in thousands):

 

 

Amount

 

Remainder of fiscal 2022

 

$

4,050

 

2023

 

 

8,100

 

2024

 

 

6,075

 

2025

 

 

55,125

 

2026

 

 

8,100

 

Thereafter

 

 

765,450

 

Total

 

$

846,900

 

 

 

11


Table of Contents

Note 10—Income Taxes

Our effective income tax rate was a benefit of 29.0% for the six months ended April 2, 2022, compared to a benefit of 32.4% for the six months ended April 3, 2021. The difference between the statutory rate and our effective rate for the six months ended April 2, 2022, was primarily attributable to state taxes. The difference between the statutory rate and our effective rate for the six months ended April 3, 2021, was primarily attributable to a reduction in the valuation allowance for our interest limitation carryforward and state taxes. Our effective income tax rate can fluctuate due to factors including valuation allowances, changes in tax laws, federal and state audits, and the impact of other discrete items.

Note 11—Commitments & Contingencies

Contingencies

We are defendants in lawsuits or potential claims encountered in the normal course of business. When the potential liability from a matter can be estimated and the loss is considered probable, we record the estimated loss. Due to uncertainties related to the resolution of lawsuits, investigations and claims, the ultimate outcome may differ from the estimates. We do not expect that the resolutions of any of these matters will have a material effect to our condensed consolidated financial position or results of operations. We did not record any material loss contingencies as of April 2, 2022, October 2, 2021, and April 3, 2021, respectively.

Our workers’ compensation insurance program, general liability insurance program, and employee group medical plan have self-insurance retention features of up to $0.4 million per event as of April 2, 2022 and October 2, 2021. We had standby letters of credit outstanding in the amounts of $10.0 million as of April 2, 2022 for the purpose of securing such obligations under our workers’ compensation self-insurance programs.

Note 12—Related Party Transactions

In February 2017, we entered into a management services agreement with our private equity sponsors in connection with our acquisition in February 2017. The management services agreement provided that we pay an annual fee for management and advisory services to us and our affiliates, including general management consulting services, support and analysis with respect to financing alternatives and strategic planning functions. The management services agreement terminated in October 2020 in connection with the completion of our initial public offering (“IPO”). During the six months ended April 3, 2021, we paid or accrued management fees in the amount of $0.4 million.

On December 14, 2021, the Company entered into a share repurchase agreement with Bubbles Investor Aggregator, L.P. and Explorer Investment Pte. Ltd. (together, the “Selling Stockholders”), each a greater than 5% beneficial owner of the Company’s common stock, providing for the repurchase by the Company from the Selling Stockholders of an aggregate of 7.5 million shares of common stock, conditioned on the closing of a contemporaneous secondary public offering (the “Offering”). The price per share of repurchased common stock paid by the Company was $20.25, which represents the per share price at which shares of common stock were sold to the public in the Offering less the underwriting discount. The repurchase transaction closed on December 16, 2021. See Note 13—Share Repurchase Program for detailed information regarding the repurchase program.

Note 13—Share Repurchase Program

On December 3, 2021, the Board of Directors authorized a share repurchase program for up to an aggregate amount of $300 million of the Company’s outstanding shares of common stock over a period of three years. The amount and timing of repurchases depends on a number of factors, including the Company’s financial condition, capital requirements, cash flows, results of operations, future business prospects, and other factors our management may deem relevant. The timing, volume, and nature of repurchases, are subject to market conditions, applicable securities laws and other factors and may be amended, suspended or discontinued at any time. Shares may be repurchased from time to time on the open market, in privately negotiated transactions, or otherwise.

On December 16, 2021, the Company repurchased and retired 7.5 million shares of common stock at a price per share of $20.25. The Company paid $151.9 million ($152.1 million including offering costs) to fund the share repurchase using existing cash on hand. The Company accounted for the share repurchase and retirement under the cost method by deducting its par value from common stock, reducing additional paid-in-capital by $127.5 million using the share price when the stock was originally issued, and the remaining

12


Table of Contents

excess cost of $24.4 million increased retained deficit. As of April 2, 2022, $148.1 million remained available for future purchases under the program.

The following table presents information about our repurchases of common stock (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Total number of shares repurchased

 

 

 

 

 

 

 

 

7,500

 

 

 

 

Total amount paid for shares repurchased

 

$

 

 

$

 

 

$

151,875

 

 

$

 

 

Note 14—Equity-Based Compensation

Equity-Based Compensation

2020 Omnibus Incentive Plan

In October 2020, we adopted the Leslie’s, Inc. 2020 Omnibus Incentive Plan (the “Plan”). The Plan provides for the grant of awards such as stock options to purchase Leslie’s common stock (each, a “Stock Option”) and restricted stock units (“RSUs”) which may settle in Leslie’s, Inc. common stock to our directors, executives and eligible employees of the Company. Stock Options granted under the Plan generally expire ten years from the date of grant and consist of Stock Options that vest upon the satisfaction of time-based requirements (“Service Stock Option”) and performance-based Stock Options that vest upon satisfaction of a performance-based requirement (“Performance Stock Options”). RSUs consist of grants that vest ratably upon the satisfaction of time-based requirements (“Service RSU”) and performance-based RSUs that vest upon satisfaction of performance-based requirements (“Performance RSU”). In each case, vesting of the Company’s outstanding and unvested Stock Options and RSUs is contingent upon the holder’s continued service through the date of each applicable vesting event. As of April 2, 2022, we had approximately 7.5 million shares of common stock available for future grants under the Plan.

As of April 2, 2022, the aggregate unamortized value of all outstanding equity-based compensation awards was approximately $34.8 million, which is expected to be recognized over a weighted average period of approximately 2.8 years.

Stock Options

The following tables summarizes our Stock Option activity under the Plan during the six months ended (in thousands, except per share amounts):

 

 

April 2, 2022

 

 

 

Number of Options

 

 

Weighted Average
Exercise Price

 

Outstanding, Beginning

 

 

4,877

 

 

$

18.22

 

Granted

 

 

 

 

 

 

Exercised

 

 

(19

)

 

 

17.00

 

Forfeited

 

 

(334

)

 

 

18.33

 

Balance, Ending

 

 

4,524

 

 

$

18.22

 

 

 

 

 

 

 

 

Vested as of April 2, 2022(1)

 

 

1,363

 

 

$

17.71

 

(1)
Includes 550,736 stock options that were subject to the Company’s achievement of the fiscal 2021 net income target which was deemed to have been met during the six months ended April 2, 2022.

 

 

 

As of April 2, 2022

 

Aggregate intrinsic value of options outstanding

 

$

12,009

 

Unamortized value of unvested stock options

 

$

12,122

 

Weighted average period (years) that expense is expected to be recognized

 

 

2.1

 

Weighted average remaining contractual life (years) for options outstanding

 

 

9.0

 

 

13


Table of Contents

Restricted Stock Units

The following table summarizes our RSU activity under the Plan during the six months ended (in thousands, except per share amounts):

 

 

April 2, 2022

 

 

 

Number of RSUs

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding, Beginning

 

 

3,135

 

 

$

6.90

 

Granted

 

 

455

 

 

 

19.94

 

Vested

 

 

(444

)

 

 

4.13

 

Forfeited

 

 

(276

)

 

 

6.76

 

Balance, Ending

 

 

2,870

 

 

$

9.41

 

 

 

 

As of April 2, 2022

 

Unamortized value of unvested RSUs

 

$

22,701

 

Weighted average period (years) expense is expected to be recognized

 

 

3.2

 

During the three and six months ended April 2, 2022, equity-based compensation expense was $2.9 million and $5.7 million, respectively, and includes Company related payroll tax expense. During the three months ended April 3, 2021, equity-based compensation expense was $2.0 million. During the six months ended April 3, 2021, equity-based compensation expense was $14.1 million and was primarily due to the vesting of performance-based equity units as a result of the Company’s IPO. These costs are reported in selling, general and administrative expenses (“SG&A”) in our condensed consolidated statements of operations.

Note 15—Earnings Per Share

The following is a reconciliation of basic weighted average common shares outstanding to diluted weighted average common shares outstanding (in thousands, except per share amounts):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(7,440

)

 

$

(6,452

)

 

$

(21,891

)

 

$

(36,709

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

 

 

 

 

 

 

 

 

 

 

RSUs

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - diluted

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

Diluted earnings per share

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

 

The following number of weighted-average potentially dilutive shares were excluded from the calculation of diluted earnings per share because the effect of including such shares would have been antidilutive (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Stock options

 

 

811

 

 

 

760

 

 

 

860

 

 

 

437

 

RSUs

 

 

2,467

 

 

 

5,505

 

 

 

2,652

 

 

 

4,673

 

Total

 

 

3,278

 

 

 

6,265

 

 

 

3,512

 

 

 

5,110

 

 

14


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of our financial condition and results of operations should be read together with our condensed consolidated financial statements and related notes, which are included elsewhere in this Quarterly Report on Form 10-Q. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Actual results or outcomes may differ materially from those anticipated in these forward-looking statements, which is subject to risks, uncertainties, and other factors described in Part l, Item 1A,Risk Factors of our Annual Report on Form 10-K for the fiscal year ended October 2, 2021, and elsewhere in this Quarterly Report on Form 10-Q, and in our other filings with the Securities and Exchange Commission.

We operate on a fiscal calendar that results in a fiscal year consisting of a 52- or 53-week period ending on the Saturday closest to September 30th. In a 52-week fiscal year, each quarter contains 13 weeks of operations; in a 53-week fiscal year, each of the first, second and third quarters includes 13 weeks of operations, and the fourth quarter includes 14 weeks of operations. References to fiscal 2022 refer to the fiscal year ended October 1, 2022. Fiscal 2022 included 52 weeks of operations.

Our Company

We are the largest and most trusted direct-to-consumer brand in the $14 billion United States pool and spa care industry, serving residential and professional consumers. Founded in 1963, we are the only direct-to-consumer pool and spa care brand with national scale, operating an integrated marketing and distribution ecosystem powered by a physical network of 965 branded locations and a robust digital platform. We offer an extensive assortment of professional-grade products, the majority of which are exclusive to Leslie’s, as well as certified installation and repair services, all of which are essential to the ongoing maintenance of pools and spas. Our dedicated team of associates, pool and spa care experts, and experienced service technicians are passionate about empowering our consumers with the knowledge, products, and solutions necessary to confidently maintain and enjoy their pools and spas. The considerable scale of our integrated marketing and distribution ecosystem, which is powered by our direct-to-consumer network, uniquely enables us to efficiently reach and service every pool and spa in the continental United States.

We operate primarily in the pool and spa aftermarket industry, which is one of the most fundamentally attractive consumer categories given its scale, predictability, and growth outlook. We have a highly predictable, recurring revenue model, as evidenced by our 58 consecutive years of sales growth. Approximately 80% of our assortment is comprised of non-discretionary products essential to the care of residential and commercial pools and spas. Our assortment includes chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. We also offer important essential services, such as equipment installation and repair for residential consumers and professional pool operators. Consumers receive the benefit of extended vendor warranties on purchased products from our locations and on installations or repairs from our certified in-field technicians. We offer complimentary, commercial-grade in-store water testing and analysis via our proprietary AccuBlue® system, which increases consumer engagement, conversion, basket size, and loyalty, resulting in higher lifetime value. Our water treatment expertise is powered by data and intelligence accumulated from the millions of water tests we have performed over the years, positioning us as the most trusted water treatment service provider in the industry. Due to the non-discretionary nature of our products and services, our business has historically delivered strong, uninterrupted growth and profitability in all market environments, including through the Great Recession and the COVID-19 pandemic.

We have a legacy of leadership and disruptive innovation. Since our founding in 1963, we have been the leading innovator in our category and have provided our consumers with the most advanced pool and spa care available. As we have scaled, we have leveraged our competitive advantages to strategically reinvest in our business and intellectual property to develop new value-added capabilities. Over the course of our history, we have pioneered complimentary in-store water testing, offered complimentary in-store equipment repair services, introduced the industry’s first loyalty program, and developed an expansive platform of owned and exclusive brands. These differentiated capabilities allow us to meet the needs of any pool and spa owner, whether they care for their pool or spa themselves or rely on a professional, whenever, wherever, and however they choose to engage with us.

Key Factors and Measures We Use to Evaluate Our Business

We consider a variety of financial and operating measures in assessing the performance of our business. The key measures we use under United States GAAP are sales, gross profit and gross margin, SG&A, and operating income (loss). The key non-GAAP measures and other operating measures we use are comparable sales, comparable sales growth, Adjusted EBITDA, Adjusted net income (loss), and Adjusted earnings per share.

 

15


Table of Contents

Sales

We offer a broad range of products that consists of regularly purchased, non-discretionary pool and spa maintenance items such as chemicals, equipment, cleaning accessories and parts, as well as installation and repair services for pool and spa equipment. Our offering of proprietary, owned and third-party brands across diverse product categories drives sales growth by attracting new consumers and encouraging repeat visits from our existing consumers. Revenue from merchandise sales at retail locations is recognized at the point of sale, revenue from services is recognized when the services are rendered, and revenue from e-commerce merchandise sales is generally recognized upon shipment of the merchandise. Revenue is recorded net of related discounts and sales tax. Payment from retail customers is generally at the point of sale and payment terms for professional pool operator customers are based on our credit requirements and generally have terms of less than 60 days. When we receive payment from a consumer before the consumer has taken possession of the merchandise or the service has been performed, the amount received is recorded as deferred revenue or as a customer deposit until the sale or service is complete. Sales are impacted by product mix and availability, as well as promotional and competitive activities and the spending habits of our consumers. Growth of our sales is primarily driven by comparable sales growth and expansion of our locations in existing and new markets.

Comparable Sales and Comparable Sales Growth

We measure comparable sales growth as the increase or decrease in sales recorded by the comparable base in any reporting period, compared to sales recorded by the comparable base in the prior reporting period. The comparable base includes sales through our locations and through our e-commerce websites and third-party marketplaces. Comparable sales is a key measure used by management and our board of directors to assess our financial performance.

We consider a new or acquired location comparable in the first full month after it has completed 52 weeks of sales. Closed locations become non-comparable during their last partial month of operation. Locations that are relocated are considered comparable at the time the relocation is complete. Comparable sales is not calculated in the same manner by all companies, and accordingly, are not necessarily comparable to similarly titled measures of other companies and may not be an appropriate measure for performance relative to other companies.

The number of new locations reflects the number of locations opened during a particular reporting period. New locations require an initial capital investment in location build-outs, fixtures, and equipment, which we amortize over time as well as cash required for inventory.

As of April 2, 2022, we operated 965 retail locations in 38 states across the United States. We owned 27 locations and leased the remainder of our locations. Our initial lease terms are typically five years with options to renew for multiple successive five-year periods. We evaluate new opportunities in new and existing markets based on the number of pools and spas in the market, competition, our existing locations, availability and cost of real estate, and distribution and operating costs of our locations. We review performance of our locations on a regular basis and evaluate opportunities to strategically close locations to improve our profitability. Our limited investment costs in individual locations and our ability to transfer sales to our extensive network of remaining locations and e-commerce websites allows us to improve profitability as a result of any strategic closures.

Gross Profit and Gross Margin

Gross profit is equal to our sales less our cost of merchandise and services sold. Cost of merchandise and services sold reflects the direct cost of purchased merchandise, costs to package certain chemical products, including direct materials and labor, costs to provide services, including labor and materials, as well as distribution and occupancy costs. The direct cost of purchased merchandise includes vendor rebates, which are generally treated as a reduction of merchandise costs. We recognize such vendor rebates at the time the obligations to purchase products or perform services have been completed, and the related inventory has been sold. Distribution costs include warehousing and transportation expenses, including costs associated with third-party fulfillment centers used to ship merchandise to our e-commerce consumers. Occupancy costs include the rent, common area maintenance, real estate taxes, and depreciation and amortization costs of all retail locations. These costs are significant and are expected to continue increase proportionate to our growth.

Gross margin is gross profit as a percentage of our sales. Gross margin is impacted by merchandise costs, pricing and promotions, product mix and availability, inflation, and service costs, which can vary. Our proprietary brands, custom-formulated products, and vertical integration provide us with cost savings, as well as greater control over product availability and quality as compared to other companies in the industry. Gross margin is also impacted by the costs of distribution and occupancy costs, which can vary.

Our gross profit is variable in nature and generally follows changes in sales. The components of our cost of merchandise and services sold may not be comparable to the components of cost of sales or similar measures of other companies. As a result, our gross profit and gross margin may not be comparable to similar data made available by other companies.

16


Table of Contents

Selling, General and Administrative Expenses

Our SG&A includes selling and operating expenses across our retail locations, digital platform, and corporate-level general and administrative expenses. Selling and operating expenses at retail locations include payroll, bonus and benefit costs for personnel, supplies, and credit and debit card processing costs. Corporate expenses include payroll, bonus, and benefit costs for our corporate and field support functions, equity-based compensation, marketing and advertising, insurance, utilities, occupancy costs related to our corporate office facilities, professional services, and depreciation and amortization for all assets, except those related to our retail locations and distribution operations, which are included in cost of merchandise and services sold. Selling and operating expenses generally vary proportionately with sales and the change in the number of locations. In contrast, general and administrative expenses are generally not directly proportional to sales and the change in the number of locations but are expected to increase over time to support our growth and public company obligations. The components of our SG&A may not be comparable to the components of similar measures of other companies.

Operating Income (Loss)

Operating income (loss) is gross profit less SG&A. Operating income (loss) excludes interest expense, loss on debt extinguishment, income tax expense (benefit), and other expenses, net. We use operating income (loss) as an indicator of the productivity of our business and our ability to manage expenses.

Adjusted EBITDA

Adjusted EBITDA is defined as earnings before interest (including amortization of debt issuance costs), taxes, depreciation and amortization, management fees, equity-based compensation expense, loss on debt extinguishment, costs related to equity offerings, strategic project costs, executive transition costs, loss (gain) on disposition of assets, mark-to-market on interest rate cap, and other non-recurring, non-cash or discrete items. Adjusted EBITDA is a key measure used by management and our board of directors to assess our financial performance. Adjusted EBITDA is also frequently used by analysts, investors and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures. We use Adjusted EBITDA to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions and to compare our performance against that of other companies using similar measures.

Adjusted EBITDA is not a recognized measure of financial performance under GAAP but is used by some investors to determine a company’s ability to service or incur indebtedness. Adjusted EBITDA is not calculated in the same manner by all companies, and accordingly, is not necessarily comparable to similarly entitled measures of other companies and may not be an appropriate measure for performance relative to other companies. Adjusted EBITDA should not be construed as an indicator of a company’s operating performance in isolation from, or as a substitute for, net income (loss), cash flows from operations or cash flow data, all of which are prepared in accordance with GAAP. We have presented Adjusted EBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations. Adjusted EBITDA is not intended to represent, and should not be considered more meaningful than, or as an alternative to, measures of operating performance as determined in accordance with GAAP. In the future, we may incur expenses or charges such as those added back to calculate Adjusted EBITDA. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these items.

Adjusted Net Income (Loss) and Adjusted Earnings per Share

Adjusted net income (loss) and Adjusted earnings per share are additional key measures used by management and our board of directors to assess our financial performance. Adjusted net income (loss) and Adjusted earnings per share are also frequently used by analysts, investors, and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures.

Adjusted net income (loss) is defined as net income (loss) adjusted to exclude management fees, equity-based compensation expense, loss on debt extinguishment, costs related to equity offerings, strategic project costs, executive transition costs, loss (gain) on disposition of assets, mark-to-market on interest rate cap, and other non-recurring, non-cash or discrete items. Adjusted diluted earnings per share is defined as Adjusted net income (loss) divided by the diluted weighted average number of common shares outstanding.

17


Table of Contents

Factors Affecting the Comparability of our Results of Operations

Our reported results have been affected by, among other events, the following events, which must be understood in order to assess the comparability of our period-to-period financial performance and condition.

Impact of COVID-19

We continue to closely monitor the ongoing impact of COVID-19 on all aspects of our business and in all of our locations. Closures and restrictions did not have a material impact on our performance during the 13 weeks ended April 2, 2022 and April 3, 2021, respectively. We remain committed to supporting federal, state, and local mandates to prevent the spread of COVID-19 while we operate our business and to do our part in protecting public health.

We help keep our communities safe from serious public health risks by providing essential products and services. Water that is not properly maintained can serve as a breeding ground for potentially fatal bacteria and viruses.

As a business, the health and safety of our consumers, communities, and associates remain our highest priority, and we continue to take all precautions recommended by the Centers for Disease Control and Prevention to ensure their safety and well-being. We have proactively implemented extensive measures in response to COVID-19 throughout our business operations, including:

Required employees who are experiencing symptoms or have been in close contact with someone who has symptoms or have been exposed to the coronavirus to stay home;
Provided additional employee benefits related to COVID-19, including paid sick leave while employees recover from receiving the COVID-19 vaccine;
Provided vaccination clinics for our employees at our corporate office and distribution centers;
Distributed personal protective equipment and implemented new monitoring protocols, including the installation of contactless temperature scanners in our corporate offices and distribution centers;
Enhanced facility cleaning including routine sanitization of high touch surfaces;
Implemented social distancing guidelines in our locations;
Implemented mask guidelines for all locations and distribution centers;
Encouraged contactless payments and introduced curbside pickup and contact-free service calls;
Executed remote workforce plan for associates in our corporate offices. Effective October 2021, all corporate office employees returned to work at the corporate office on a hybrid schedule; and
Effective October 2021, enacted a vaccination policy requiring certain employees to provide proof of vaccination or receive a religious or medical exemption. The vaccination policy currently applies to all corporate office employees.

We have also closely coordinated with our vendor partners to minimize the impact of supply disruptions and maintain the flow of essential products to meet the elevated demand from consumers in the current environment. The full impact of COVID-19 on our financial and operating performance depends significantly on the duration and severity of the pandemic, the actions taken to contain or mitigate its impact, and any changes in consumer behaviors. It is not possible to predict the likelihood, timing, or severity of the aforementioned direct and indirect impacts of COVID-19 on our business. Restrictions on the operation of our locations and distribution facilities could have a material impact on our sales and earnings. COVID-19 could also lead to significant disruption to our supply chain for products we sell and could have a material impact on our sales and earnings.

Business Acquisitions

Our business acquisitions did not have a material impact on our financial position or results of operations. See Note 3—Business Combinations to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for information regarding our business acquisitions.

 

18


Table of Contents

Incremental Public Company Expenses

As a newly public company we will incur significant expenses on an ongoing basis that we did not incur as a private company. Those costs include additional director compensation and director and officer liability insurance expenses, as well as third-party and internal resources related to accounting, auditing, Sarbanes-Oxley Act compliance, legal, and investor and public relations expenses. These costs will generally be included in SG&A in our condensed consolidated statements of operations.

19


Table of Contents

Results of Operations

We derived our condensed consolidated statements of operations for the 13- and 26- weeks ended April 2, 2022 and April 3, 2021 from our condensed consolidated financial statements. Our historical results are not necessarily indicative of the results that may be expected in the future. The following table summarizes key components of our results of operations for the periods indicated, both in dollars and as a percentage of our sales (in thousands, except per share amounts).

 

 

Three Months Ended

 

 

Six Months Ended

 

Statements of Operations data:

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Sales

 

$

228,072

 

 

$

192,441

 

 

$

412,896

 

 

$

337,447

 

Cost of merchandise and services sold

 

 

142,443

 

 

 

120,758

 

 

 

259,951

 

 

 

214,049

 

Gross profit

 

 

85,629

 

 

 

71,683

 

 

 

152,945

 

 

 

123,398

 

Selling, general and administrative expenses

 

 

89,618

 

 

 

70,374

 

 

 

169,403

 

 

 

147,863

 

Operating (loss) income

 

 

(3,989

)

 

 

1,309

 

 

 

(16,458

)

 

 

(24,465

)

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

6,949

 

 

 

8,126

 

 

 

13,812

 

 

 

19,642

 

Loss on debt extinguishment

 

 

 

 

 

1,888

 

 

 

 

 

 

9,169

 

Other expenses, net

 

 

161

 

 

 

1,057

 

 

 

550

 

 

 

1,057

 

Total other expense

 

 

7,110

 

 

 

11,071

 

 

 

14,362

 

 

 

29,868

 

Loss before taxes

 

 

(11,099

)

 

 

(9,762

)

 

 

(30,820

)

 

 

(54,333

)

Income tax benefit

 

 

(3,659

)

 

 

(3,310

)

 

 

(8,929

)

 

 

(17,624

)

Net loss

 

$

(7,440

)

 

$

(6,452

)

 

$

(21,891

)

 

$

(36,709

)

Earnings per share

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

Diluted

 

$

(0.04

)

 

$

(0.03

)

 

$

(0.12

)

 

$

(0.20

)

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

Diluted

 

 

182,678

 

 

 

186,810

 

 

 

185,592

 

 

 

181,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage of Sales(1)

 

(%)

 

 

(%)

 

 

(%)

 

 

(%)

 

Sales

 

 

100.0

 

 

 

100.0

 

 

 

100.0

 

 

 

100.0

 

Cost of merchandise and services sold

 

 

62.5

 

 

 

62.8

 

 

 

63.0

 

 

 

63.4

 

Gross margin

 

 

37.5

 

 

 

37.2

 

 

 

37.0

 

 

 

36.6

 

Selling, general and administrative expenses

 

 

39.3

 

 

 

36.6

 

 

 

41.0

 

 

 

43.8

 

Operating (loss) income

 

 

(1.7

)

 

 

0.7

 

 

 

(4.0

)

 

 

(7.3

)

Other expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

3.0

 

 

 

4.2

 

 

 

3.3

 

 

 

5.8

 

Loss on debt extinguishment

 

 

 

 

 

1.0

 

 

 

 

 

 

2.7

 

Other expenses, net

 

 

0.1

 

 

 

0.5

 

 

 

0.1

 

 

 

0.3

 

Total other expense

 

 

3.1

 

 

 

5.8

 

 

 

3.5

 

 

 

8.9

 

Loss before taxes

 

 

(4.9

)

 

 

(5.1

)

 

 

(7.5

)

 

 

(16.1

)

Income tax benefit

 

 

(1.6

)

 

 

(1.7

)

 

 

(2.2

)

 

 

(5.2

)

Net loss

 

 

(3.3

)

 

 

(3.4

)

 

 

(5.3

)

 

 

(10.9

)

Other Financial and Operations data:

 

 

 

 

 

 

 

 

 

 

 

 

Number of new and acquired locations, net

 

 

6

 

 

 

4

 

 

 

13

 

 

 

4

 

Number of locations open at end of period

 

 

965

 

 

 

940

 

 

 

965

 

 

 

940

 

Comparable sales growth(2)

 

 

13.3

%

 

 

51.3

%

 

 

16.4

%

 

 

33.7

%

Adjusted EBITDA(3)

 

$

8,696

 

 

$

9,528

 

 

$

9,792

 

 

$

9,285

 

Adjusted EBITDA as a percentage of sales(3)

 

 

3.8

%

 

 

5.0

%

 

 

2.4

%

 

 

2.8

%

Adjusted net loss(3)

 

$

(2,738

)

 

$

(2,781

)

 

$

(13,654

)

 

$

(13,400

)

Adjusted diluted earnings per share

 

$

(0.01

)

 

$

(0.01

)

 

$

(0.07

)

 

$

(0.07

)

 

(1)
Components may not add to totals due to rounding.
(2)
See the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Key Factors and Measures We Use to Evaluate Our Business.”
(3)
The tables below provide a reconciliation from our net loss to Adjusted EBITDA and net loss to Adjusted net loss for the 13 and 26 weeks ended April 2, 2022 and April 3, 2021, respectively (in thousands).

 

20


Table of Contents

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Net loss

 

$

(7,440

)

 

$

(6,452

)

 

$

(21,891

)

 

$

(36,709

)

Interest expense

 

 

6,949

 

 

 

8,126

 

 

 

13,812

 

 

 

19,642

 

Income tax benefit

 

 

(3,659

)

 

 

(3,310

)

 

 

(8,929

)

 

 

(17,624

)

Depreciation and amortization expense(1)

 

 

6,576

 

 

 

6,263

 

 

 

15,817

 

 

 

12,858

 

Management fees(2)

 

 

 

 

 

 

 

 

 

 

 

382

 

Equity-based compensation expense(3)

 

 

2,918

 

 

 

1,951

 

 

 

5,712

 

 

 

14,111

 

Loss on debt extinguishment(4)

 

 

 

 

 

1,888

 

 

 

 

 

 

9,169

 

Costs related to equity offerings(5)

 

 

161

 

 

 

1,057

 

 

 

550

 

 

 

9,209

 

Strategic project costs(6)

 

 

2,274

 

 

 

 

 

 

3,787

 

 

 

 

Executive transition costs and other(7)

 

 

917

 

 

 

5

 

 

 

934

 

 

 

(1,753

)

Adjusted EBITDA

 

$

8,696

 

 

$

9,528

 

 

$

9,792

 

 

$

9,285

 

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

 

April 2, 2022

 

 

April 3, 2021

 

Net loss

 

$

(7,440

)

 

$

(6,452

)

 

$

(21,891

)

 

$

(36,709

)

Management fees(2)

 

 

 

 

 

 

 

 

 

 

 

382

 

Equity-based compensation expense(3)

 

 

2,918

 

 

 

1,951

 

 

 

5,712

 

 

 

14,111

 

Loss on debt extinguishment(4)

 

 

 

 

 

1,888

 

 

 

 

 

 

9,169

 

Costs related to equity offerings(5)

 

 

161

 

 

 

1,057

 

 

 

550

 

 

 

9,209

 

Strategic project costs(6)

 

 

2,274

 

 

 

 

 

 

3,787

 

 

 

 

Executive transition costs and other(7)

 

 

917

 

 

 

5

 

 

 

934

 

 

 

(1,753

)

Tax effects of these adjustments(8)

 

 

(1,568

)

 

 

(1,230

)

 

 

(2,746

)

 

 

(7,809

)

Adjusted net loss

 

$

(2,738

)

 

$

(2,781

)

 

$

(13,654

)

 

$

(13,400

)

 

(1)
Includes depreciation related to our distribution centers and locations, which is reported in cost of merchandise and services sold in our condensed consolidated statements of operations.
(2)
Represents amounts paid or accrued in connection with our management services agreement, which was terminated upon the completion of our IPO in November 2020 and are reported in SG&A in our condensed consolidated statements of operations.
(3)
Represents charges related to equity-based compensation and the related Company payroll tax expense which are reported in SG&A in our condensed consolidated statements of operations.
(4)
Represents non-cash expense due to the write-off of deferred financing costs related to the Term Loan modification during the three months ended April 3, 2021 and the repayment of our senior unsecured notes during the six months ended April 3, 2021 which are reported in loss on debt extinguishment in our condensed consolidated statements of operations.
(5)
Includes one-time payments of contractual amounts incurred in connection with our IPO that was completed in November 2020 which are reported in SG&A, and costs incurred for follow-on equity offerings in December 2021 which are reported in other expenses, net in our condensed consolidated statements of operations.
(6)
Represents non-recurring costs, such as third-party consulting costs that are not part of our ongoing operations and are incurred to execute differentiated, strategic projects, and are reported in SG&A in our condensed consolidated statements of operations.
(7)
Includes executive transition costs, losses (gains) on disposition of fixed assets and other non-recurring, non-cash or discrete items as determined by management. Amounts are reported in SG&A and other expenses, net in our condensed consolidated statements of operations.
(8)
Represents the tax effect of the total adjustments based on our actual statutory tax rate. Amounts are reported in income tax benefit in our condensed consolidated statements of operations.

21


Table of Contents

Selected Financial Information

Sales

Sales increased to $228.1 million for the three months ended April 2, 2022, from $192.4 million in the prior year period, an increase of $35.7 million, or 18.5%. The increase was primarily driven by higher comparable sales growth of $25.5 million, or 13.3% in the current year period as well as non-comparable sales growth driven by acquisitions and new locations open for less than 52 weeks.

Sales increased to $412.9 million for the six months ended April 2, 2022, from $337.4 million in the prior year period, an increase of $75.5 million, or 22.4%. The increase was primarily driven by higher comparable sales growth of $55.2 million, or 16.4% in the current year period as well as non-comparable sales growth driven by acquisitions and new locations open for less than 52 weeks

We believe that COVID-19 has accelerated secular trends in consumer behavior and has favorably impacted our sales. While the duration and effects of the COVID-19 pandemic are uncertain, we anticipate that the changes in consumer behavior will continue for the foreseeable future.

Gross Profit and Gross Margin

Gross profit increased to $85.6 million for the three months ended April 2, 2022 from $71.7 million in the prior year period, an increase of $13.9 million, or 19.5%. Gross margin increased to 37.5% compared to 37.2% in the prior year period, an increase of 30 basis points.

Gross profit increased to $152.9 million for the six months ended April 2, 2022 from $123.4 million in the prior year period, an increase of $29.5 million, or 23.9%. Gross margin increased to 37.0% compared to 36.6% in the prior year period, an increase of 40 basis points.

These increases in gross profit were primarily due to product margin improvements and occupancy leverage, partially offset by business mix.

Selling, General and Administrative Expenses

SG&A increased to $89.6 million for the three months ended April 2, 2022 from $70.4 million in the prior year period, an increase of $19.2 million, or 27.3%. This increase in SG&A was primarily related to a $15.2 million increase associated with higher sales, M&A, and other investments to support Company growth, a $3.0 million increase primarily related to strategic project costs incurred in the second quarter of fiscal 2022, and higher non-cash equity-based compensation expense of $1.0 million.

SG&A increased to $169.4 million for the six months ended April 2, 2022 from $147.9 million in the prior year period, an increase of $21.5 million, or 14.6%. This increase in SG&A was primarily related to a $31.7 million increase associated with higher sales, M&A, and other investments to support Company growth, a $2.6 million reduction primarily in gain on sale of assets realized in the first half of fiscal 2021, and a $3.8 million increase related to strategic project costs incurred in the first half of fiscal 2022. This increase was offset by lower non-cash equity-based compensation costs of $8.4 million and certain one-time payments of contractual amounts of $8.2 million, as compared to the prior year period. These offsets were primarily incurred in connection with our IPO in the first half of fiscal 2021.

Total Other Expense

Total other expenses decreased to $7.1 million for the three months ended April 2, 2022 from $11.1 million in the prior year period, a decrease of $4.0 million. Total other expenses decreased to $14.4 million for the six months ended April 2, 2022 from $29.9 million in the prior year period, a decrease of $15.5 million.

These decreases were primarily driven by $1.9 million and $9.2 million of non-cash loss on debt extinguishment related to the refinancing of the Term Loan and repayment of our senior unsecured notes during the three and six months ended April 2, 2021, respectively, and lower interest expenses related to the repayment of our senior unsecured notes with the proceeds of our IPO in November 2020 of $1.2 million and $5.8 million, respectively.

Income Taxes

Income tax benefit increased to $3.7 million for the three months ended April 2, 2022 from $3.3 million in the prior year period, an increase of $0.4 million. Income tax benefit decreased to $8.9 million for the six months ended April 2, 2022, from $17.6 million in the prior year period, a decrease of $8.7 million.

The effective income tax rate was a benefit of 33.0% and 29.0% for the three and six months ended April 2, 2022, respectively, and includes the net income tax benefits attributable to equity-based compensation awards and research and development credits. The effective income tax rate was 33.9% and 32.4% for the three and six months ended April 3, 2021, respectively, and includes a decrease in the valuation allowance for our interest limitation carryforward and net income tax benefits attributable to equity-based compensation awards.

22


Table of Contents

Net Loss and Earnings per Share

Net loss was $7.4 million for the three months ended April 2, 2022 compared to a net loss of $6.5 million in the prior year period. Net loss decreased to $21.9 million for the six months ended April 2, 2022 compared to a net loss of $36.7 million in the prior year period, an improvement of $14.8 million.

Diluted earnings per share was $(0.04) for the three months ended April 2, 2022 compared to $(0.03) in the prior year period. Diluted earnings per share improved to $(0.12) for the six months ended April 2, 2022 from $(0.20) in the prior year period.

Adjusted net loss improved slightly to $2.7 million for the three months ended April 2, 2022 compared to an Adjusted net loss of $2.8 million in the prior year period. Adjusted net loss was $13.7 million for the six months ended April 2, 2022 compared to an Adjusted net loss of $13.4 million in the prior year period.

Adjusted diluted earnings per share of $(0.01) and $(0.07) for the three and six months ended April 2, 2022 remained consistent with the prior year periods.

Adjusted EBITDA

Adjusted EBITDA was $8.7 million for the three months ended April 2, 2022 compared to $9.5 million in the prior year period, a decrease of $0.8 million. Adjusted EBITDA increased to $9.8 million for the six months ended April 2, 2022 compared to $9.3 million in the prior year period, an increase of $0.5 million.

Seasonality and Quarterly Fluctuations

Our business is highly seasonal. In general, sales and earnings are highest during the third and fourth fiscal quarters, which include April through September, and represent the peak months of swimming pool use. In fiscal 2021, we generated 75% of our sales and 97% of our Adjusted EBITDA in the third and fourth quarters of our fiscal year. Sales are substantially lower during our first and second fiscal quarters. We have a long track record of investing in our business throughout the year, including in operating expenses, working capital, and capital expenditures related to new locations and other growth initiatives. While these investments drive performance during the primary selling season in our third and fourth fiscal quarters, they have a negative impact during our first and second fiscal quarters.

We experience a build-up of inventory and accounts payable during the first and second fiscal quarters in anticipation of the peak swimming pool supply selling season. We negotiate extended payment terms with certain of our primary suppliers as we receive merchandise in December through March and we pay for merchandise in April through July.

The principal external factor affecting our business is weather. Hot weather can increase purchases of chemicals and other non-discretionary products and purchases of discretionary products, and can drive increased purchases of installation and repair services. Unseasonably cool weather or significant amounts of rainfall during the peak sales season can reduce chemical consumption in pools and spas and decrease consumer purchases of our products and services. In addition, unseasonably early or late warming trends can increase or decrease the length of the pool season and impact timing around pool openings and closings and, therefore, our total sales and timing of our sales.

We generally open new locations before our peak selling season begins and we close locations after our peak selling season ends. We expect that our quarterly results of operations will fluctuate depending on the timing and amount of sales contributed by new locations.

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are net cash provided by operating activities and borrowing availability under our Revolving Credit Facility. Historically, we have funded working capital requirements, capital expenditures, payments related to acquisitions, debt service requirements and repurchases of shares of our common stock with internally generated cash on hand and through our Revolving Credit Facility.

Cash and cash equivalents consist primarily of cash on deposit with banks. Cash and cash equivalents totaled $52.0 million and $343.5 million as of April 2, 2022 and October 2, 2021, respectively. As of April 2, 2022, we had $45.0 million outstanding on our Revolving Credit Facility as compared to $0 as of October 2, 2021. Subsequent to April 2, 2022, we repaid the outstanding balance of $45.0 million on the Revolving Credit Facility.

Our primary working capital requirements are for the purchase of inventory, payroll, rent, other facility costs, distribution costs, and general and administrative costs. Our working capital requirements fluctuate during the year, driven primarily by seasonality and the timing of inventory purchases.

23


Table of Contents

Our capital expenditures are primarily related to infrastructure-related investments, including investments related to upgrading and maintaining our information technology systems, ongoing location improvements, expenditures related to our distribution centers, and new location openings. We expect to fund capital expenditures from net cash provided by operating activities.

Based on our growth plans, we believe our cash and cash equivalents position, net cash provided by operating activities and borrowing availability under our Revolving Credit Facility will be adequate to finance our working capital requirements, planned capital expenditures, share repurchases, and debt service over the next 12 months. In the future, we may also allocate capital toward additional strategic acquisitions and share repurchases. If cash provided by operating activities and borrowings under our Revolving Credit Facility are not sufficient or available to meet our capital requirements, then we may need to obtain additional equity or debt financing. There can be no assurance that equity or debt financing will be available to us if we need it or, if available, whether the terms will be satisfactory to us.

As of April 2, 2022, outstanding standby letters of credit totaled $10.0 million and, after considering borrowing base restrictions, we had $145.0 million of available borrowing capacity under the terms of the Revolving Credit Facility. As of April 2, 2022, we were in compliance with the covenants under the Revolving Credit Facility and our Term Loan agreements.

Summary of Cash Flows

A summary of our cash flows from operating, investing, and financing activities is presented in the following table (in thousands):

 

 

 

Six Months Ended

 

 

 

April 2, 2022

 

 

April 3, 2021

 

Net cash used in operating activities

 

$

(136,757

)

 

$

(111,790

)

Net cash used in investing activities

 

 

(43,903

)

 

 

(13,126

)

Net cash (used in) provided by financing activities

 

 

(110,867

)

 

 

57,847

 

Net decrease in cash and cash equivalents

 

$

(291,527

)

 

$

(67,069

)

 

Cash Used in Operating Activities

Net cash used in operating activities increased to $136.8 million for the six months ended April 2, 2022 compared to $111.8 million in the prior year period, an increase of $25.0 million. This increase was primarily driven by changes in working capital related to the strategic investment in product inventories to meet heightened customer demand across product categories.

Cash Used in Investing Activities

Net cash used in investing activities increased to $43.9 million for the six months ended April 2, 2022 compared to $13.1 million in the prior year period, an increase of $30.8 million. This increase was primarily driven by increased spend for business acquisitions of $23.9 million and investments in property and equipment of $4.8 million, partially offset by a decrease in proceeds from fixed asset dispositions of $2.0 million.

Cash (Used in) Provided by Financing Activities

Net cash used in financing activities for the six months ended April 2, 2022 of $110.9 million, was primarily related to the repurchase and retirement of common stock of $152.1 million and net repayment of long-term debt of $4.0 million, partially offset by borrowings on our Revolving Credit Facility of $45.0 million. Net cash provided by financing activities for the six months ended April 3, 2021 of $57.8 million, was primarily related to proceeds raised during our IPO in November 2020 of $458.6 million, partially offset by the net repayment of long-term debt and deferred financing costs totaling $ 400.7 million.

Share Repurchase Program

On December 3, 2021, the Board of Directors authorized a share repurchase program for up to an aggregate amount of $300 million of the Company’s outstanding shares of common stock over a period of three years. The amount and timing of repurchases depends on a number of factors, including the Company's financial condition, capital requirements, cash flows, results of operations, future business prospects and other factors our management may deem relevant. The timing, volume and nature of repurchases, are subject to market conditions, applicable securities laws and other factors and may be amended, suspended or discontinued at any time. Shares may be repurchased from time to time on the open market, in privately negotiated transactions, or otherwise.

 

24


Table of Contents

On December 16, 2021, the Company repurchased and retired 7.5 million shares of common stock at a price per share of $20.25. The Company paid $151.9 million ($152.1 million including offering costs) to fund the share repurchase using existing cash on hand. The Company accounted for the share repurchase and retirement under the cost method by deducting its par value from common stock, reducing additional paid-in-capital by $127.5 million using the share price when the stock was originally issued, and the remaining excess cost of $24.4 million increased retained deficit. As of April 2, 2022, $148.1 million remained available for future purchases under the program.

Contractual Obligations and Other Commitments

There were no material changes to our contractual obligations outside the ordinary course of our business during the three months and six months ended April 2, 2022.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements are prepared in accordance with GAAP and the applicable rules and regulations of the SEC for interim reporting. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.
 

There have been no material changes to our critical accounting policies and estimates during the 13- and 26- weeks ended April 2, 2022 from those disclosed in our Annual Report on Form 10-K for the fiscal year ended October 2, 2021.

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 2—Summary of Significant Accounting Policies to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate Risk

There have been no material changes in our primary risk exposures or management of market risks from those disclosed in our Annual Report on Form 10-K for the fiscal year ended October 2, 2021.

Impact of Inflation and Deflation

We experience inflation and deflation related to our purchase of certain products. This price volatility could potentially have a material impact on our financial condition and/or our results of operations. We actively manage the impact of inflation, including tariffs, through strong relationships with our diverse supplier base, vendor negotiation, and promotion management. We also strategically invest through inventory purchases in order to obtain favorable pricing ahead of any vendor price increases. In order to mitigate price volatility, we monitor price fluctuations and may adjust our selling prices accordingly, however, our ability to recover higher costs through increased pricing may be limited by the competitive environment in which we operate. Although we may experience periodic effects on sales, gross profit, gross margins and cash flows as a result of changing prices, including most recently from inflationary pressures due primarily to supply chain disruptions complicated by the COVID-19 pandemic, we do not expect the effect of inflation or deflation to have a material impact on our ability to execute our long-term business strategy. We currently do not use derivative instruments to manage these risks.

 

25


Table of Contents

Item 4. Controls and Procedures.

Management’s Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)) are designed to ensure that information required to be disclosed by us in reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the appropriate time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We, under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the design and operation of our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended April 2, 2022 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

26


Table of Contents

PART II - OTHER INFORMATION

We are subject to various litigations, claims and other proceedings that arise from time to time in the ordinary course of business. We believe these actions are routine and incidental to the business. As of April 2, 2022, we had established reserves for claims that are probable and estimable and such reserves were not significant. While we cannot feasibly predict the outcome of these matters with certainty, we believe, based on examination of these matters, experience to date and discussions with counsel, that the ultimate liability, individually or in the aggregate, will not have a material adverse effect on our business, financial position, results of operations or cash flows.

Item 1A. Risk Factors.

There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended October 2, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

None.

Sales of Unregistered Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

27


Table of Contents

Item 6. Exhibits.

 

 

 

 

Incorporated by Reference

Exhibit

Number

 

Exhibit Description

 

Form

 

Exhibit

 

Filing Date/

Period End Date

31.1*

 

Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

 

 

 

 

 

 

31.2*

 

Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934

 

 

 

 

 

 

32.1+

 

Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350

 

 

 

 

 

 

32.2+

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350

 

 

 

 

 

 

101.INS*

 

Inline XBRL Instance Document

 

 

 

 

 

 

101.SCH*

 

Inline XBRL Schema Document

 

 

 

 

 

 

101.CAL*

 

Inline XBRL Calculation Linkbase Document

 

 

 

 

 

 

101.LAB*

 

Inline XBRL Label Linkbase Document

 

 

 

 

 

 

101.PRE*

 

Inline XBRL Presentation Linkbase Document

 

 

 

 

 

 

101.DEF*

 

Inline XBRL Definition Linkbase Document

 

 

 

 

 

 

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

* Filed herewith.

+ Furnished herewith and not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

28


Table of Contents

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

LESLIE’S, INC.

 

 

 

 

Date: May 6, 2022

 

By:

/s/ Steven M. Weddell

 

 

 

Steven M. Weddell

 

 

 

Executive Vice President and Chief Financial Officer

 

 

 

(Principal Financial Officer and Principal Accounting Officer)

 

29